President Trump told reporters on Monday that critics who are opposed to his proposed White House ballroom are disloyal to the country. "The people that are opposing the ballroom are people that in my opinion are very disloyal to our country,” Trump said in the Oval Office. “And I think we’re doing well. I think...
Multiple White House officials on Monday took Sen. Jon Ossoff (D-Ga.) to task for his harsh criticism of President Trump at a campaign rally over the weekend. White House communications director Steven Cheung said Ossoff “has to be the biggest … loser in politics,” and referred to the lawmaker using a crude play on his...
President Trump will meet with Ryder Williams at the White House Monday afternoon, after the teen saved a 10-year-old from drowning last month in California. “We’re going to bring this heroic young man, and his family, into the White House with, perhaps, the boy he saved, to give him a High Civilian Honor,” Trump wrote...
Customs and Border Protection (CBP) Commissioner Rodney Scott said he would halt construction activity in Big Bend National Park as efforts to erect a border barrier have met bipartisan pushback. In a video posted to social media on Monday, Scott said, “Last night I put a pause on all activity in that park as far as...
Democrats have a more favorable view of socialism than capitalism, according to a new poll. In the CBS News/YouGov poll, socialism was seen in a “very positive” or “somewhat positive” light by 58 percent of Democratic respondents, with 18 percent of the same group seeing the ideology in a “somewhat negative” or “very negative” light....
GOP Rep. Don Bacon (Neb.) said Sunday he was “concerned” about President Trump saying he is not aware of the Pentagon’s missile shortage. “I do have concerns that the president said he was not aware that we had a shortage of weapons like cruise missiles and Patriots. That's not a good … thing,” Bacon told...
President Trump's executive order recommending that the measles, mumps and rubella (MMR) vaccine be split up across three appointments is drawing poor reception from the pharmaceutical industry as drugmakers and trade groups say there's no scientific reasoning to follow the directive. The administration did not provide any new scientific data to support splitting up the...